Aspect Biosystems picks up Series A
Vancouver, British Columbia-based Aspect Biosystems, a biotechnology company, has raised US$20 million in Series A financing.
9 January 2020•1 min read
Vancouver, British Columbia-based Aspect Biosystems, a biotechnology company, has raised US$20 million in Series A financing.